Last month, Huons Medical acquired medical device item authorizations for women's medical devices "JILL'SOF” and "V-Needle," a needle, from the Ministry of Food and Drug Safety.

Huons Medical, which was founded in 2013, has recently changed its name from Panace to Huons Medical in order to become a medical device manufacturer after focusing on the aesthetic medical device business.

In addition, the company has developed Dermashine, the world's first medical equipment dedicated to Mesotherapy, successfully distributing treatment technology and medical equipment to Korea and other Asian medical circles, and strive to standardize and globalize Mesotherapy treatment centered on the new Dermashine.

JILL'SOF and V-Needle are medical devices exclusively for women developed by Huons Medical to inject drugs into the vaginal affected area. 

JILL'SOF is equipped with a pressure-sensitive auto-injection system and uses hardware and software specialized for intravenous procedures. It has the advantage of being able to set the amount of drug injection and the rate of injection, enabling customized procedures for each patient.

In addition, JILL'SOF can be compatible with other syringes in addition to V-Needle, so that it can be used for various procedures.

V-Needle is made exclusively for using JILL'SOF designed to inject drugs into the affected area accurately and quickly, and has a unique structure in the form of an ergonomically designed rod.

Furthermore, the insertion depth can be checked with the instrument, allowing the safe injection of a certain amount of medication into the correct location.

Park Byung-moo, CEO of Huons Medical, said, "We have developed it to reduce the inconvenience of medical staff and patients experiencing obstetrics and urology procedures. We will make efforts to grow into our flagship product that inherit the reputation of Dermashine."